Bernard, A.; Danigo, A.; Bourthoumieu, S.; Mroué, M.; Desmoulière, A.; Sturtz, F.; Rovini, A.; Demiot, C.
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management. Pharmaceuticals 2021, 14, 1185.
https://doi.org/10.3390/ph14111185
AMA Style
Bernard A, Danigo A, Bourthoumieu S, Mroué M, Desmoulière A, Sturtz F, Rovini A, Demiot C.
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management. Pharmaceuticals. 2021; 14(11):1185.
https://doi.org/10.3390/ph14111185
Chicago/Turabian Style
Bernard, Amandine, Aurore Danigo, Sylvie Bourthoumieu, Mohamad Mroué, Alexis Desmoulière, Franck Sturtz, Amandine Rovini, and Claire Demiot.
2021. "The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management" Pharmaceuticals 14, no. 11: 1185.
https://doi.org/10.3390/ph14111185
APA Style
Bernard, A., Danigo, A., Bourthoumieu, S., Mroué, M., Desmoulière, A., Sturtz, F., Rovini, A., & Demiot, C.
(2021). The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management. Pharmaceuticals, 14(11), 1185.
https://doi.org/10.3390/ph14111185